Enterome Bioscience SA - Product Pipeline Analysis, 2018 Update

Enterome Bioscience SA - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME399424PD
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome-based biomarkers and screen for microbiome-derived molecules. It also develops new diagnostic products for patient classification and forecasting treatment response. Enterome provides microbiome-derived molecules as drug candidates. The company develops drugs for treatment of microbiome-related diseases which include metabolic, inflammatory bowel diseases, and central nervous system linked diseases. Enterome is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Enterome Bioscience SA

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Enterome Bioscience SA Company Overview 5

Enterome Bioscience SA Company Snapshot 5

Enterome Bioscience SA Pipeline Products and Ongoing Clinical Trials Overview 5

Enterome Bioscience SA-Pipeline Analysis Overview 8

Enterome Bioscience SA-Key Facts 8

Enterome Bioscience SA-Major Products and Services 9

Enterome Bioscience SA Pipeline Products by Development Stage 10

Enterome Bioscience SA Pipeline Products Overview 12

Biomarker Panel-Liver Cirrhosis 12

Biomarker Panel-Liver Cirrhosis Product Overview 12

Biomarker Test-Non-Alcoholic Fatty Liver Disease (NAFLD) 13

Biomarker Test-Non-Alcoholic Fatty Liver Disease (NAFLD) Product Overview 13

CDx Test (IBD 210) Crohn's Disease- AIEC Carriage 14

CDx Test (IBD 210) Crohn's Disease- AIEC Carriage Product Overview 14

Diagnostic Test-Autism 15

Diagnostic Test-Autism Product Overview 15

Diagnostic Test-Depression 16

Diagnostic Test-Depression Product Overview 16

Diagnostic Test-Multiple Sclerosis 17

Diagnostic Test-Multiple Sclerosis Product Overview 17

Diagnostic Test-Parkinson's Disease 18

Diagnostic Test-Parkinson's Disease Product Overview 18

Diagnostic Test-Type 2 Diabetes 19

Diagnostic Test-Type 2 Diabetes Product Overview 19

Dx test (IBD 110) Crohn's Disease-Activity Monitoring 20

Dx test (IBD 110) Crohn's Disease-Activity Monitoring Product Overview 20

EFL Test 21

EFL Test Product Overview 21

IBD 120 Ulcerative Collitis Relapse Prediction Test 22

IBD 120 Ulcerative Collitis Relapse Prediction Test Product Overview 22

IOC520 23

IOC520 Product Overview 23

MET 220 Bariatric Surgery-Outcome Prediction Test 24

MET 220 Bariatric Surgery-Outcome Prediction Test Product Overview 24

MET 230 Stratified Nutrition Test 25

MET 230 Stratified Nutrition Test Product Overview 25

Non-invasive Monitoring Tool-Cancer 26

Non-invasive Monitoring Tool-Cancer Product Overview 26

Enterome Bioscience SA-Key Competitors 27

Enterome Bioscience SA-Key Employees 28

Enterome Bioscience SA-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Enterome Bioscience SA, Recent Developments 30

Sep 20, 2017: Enterome to Move its Research Laboratories to Genopole, France's First Biocluster 30

Jul 12, 2017: Enterome Appoints Mary Thistle to its Board of Directors 30

Jul 11, 2017: Enterome and Nestle Health Sciences launch new diagnostics company 30

Dec 09, 2016: Enterome announces management changes 31

Nov 03, 2016: Enterome Appoints Christophe Bonny as Chief Scientific Officer 32

May 19, 2016: Enterome Initiates Strategic Expansion With the Opening of US Office in Cambridge, MA 32

Sep 29, 2015: Georges Gemayel Appointed Non-executive Chairman of Enterome 33

Mar 19, 2015: Oral Presentation and Poster at the IHMC congress in Luxembourg 33

Jun 17, 2014: Enterome to participate on panel at BIO2014 entitled: Microbiome Modulators: Opportunities and Challenges to Creating a New Drug Class 33

Apr 24, 2014: Enterome to Chair Panel at Forthcoming Microbiome / Microbiota R&D and Business Collaboration Forum in London, UK 34

Appendix 35

Methodology 35

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Figures

Enterome Bioscience SA Pipeline Products by Equipment Type 6

Enterome Bioscience SA Pipeline Products by Development Stage 10

List of Tables

Enterome Bioscience SA Pipeline Products and Ongoing Clinical Trials Overview 5

Enterome Bioscience SA Pipeline Products by Equipment Type 6

Enterome Bioscience SA Pipeline Products by Indication 7

Enterome Bioscience SA, Key Facts 8

Enterome Bioscience SA, Major Products and Services 9

Enterome Bioscience SA Number of Pipeline Products by Development Stage 10

Enterome Bioscience SA Pipeline Products Summary by Development Stage 11

Biomarker Panel-Liver Cirrhosis-Product Status 12

Biomarker Panel-Liver Cirrhosis-Product Description 12

Biomarker Test-Non-Alcoholic Fatty Liver Disease (NAFLD)-Product Status 13

Biomarker Test-Non-Alcoholic Fatty Liver Disease (NAFLD)-Product Description 13

CDx Test (IBD 210) Crohn's Disease- AIEC Carriage-Product Status 14

CDx Test (IBD 210) Crohn's Disease- AIEC Carriage-Product Description 14

Diagnostic Test-Autism-Product Status 15

Diagnostic Test-Autism-Product Description 15

Diagnostic Test-Depression-Product Status 16

Diagnostic Test-Depression-Product Description 16

Diagnostic Test-Multiple Sclerosis-Product Status 17

Diagnostic Test-Multiple Sclerosis-Product Description 17

Diagnostic Test-Parkinson's Disease-Product Status 18

Diagnostic Test-Parkinson's Disease-Product Description 18

Diagnostic Test-Type 2 Diabetes-Product Status 19

Diagnostic Test-Type 2 Diabetes-Product Description 19

Dx test (IBD 110) Crohn's Disease-Activity Monitoring-Product Status 20

Dx test (IBD 110) Crohn's Disease-Activity Monitoring-Product Description 20

EFL Test-Product Status 21

EFL Test-Product Description 21

IBD 120 Ulcerative Collitis Relapse Prediction Test-Product Status 22

IBD 120 Ulcerative Collitis Relapse Prediction Test-Product Description 22

IOC520-Product Status 23

IOC520-Product Description 23

MET 220 Bariatric Surgery-Outcome Prediction Test-Product Status 24

MET 220 Bariatric Surgery-Outcome Prediction Test-Product Description 24

MET 230 Stratified Nutrition Test-Product Status 25

MET 230 Stratified Nutrition Test-Product Description 25

Non-invasive Monitoring Tool-Cancer-Product Status 26

Non-invasive Monitoring Tool-Cancer-Product Description 26

Enterome Bioscience SA, Key Employees 28

Enterome Bioscience SA, Subsidiaries 29

Glossary 37

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Isochem SAS

Histalim Sarl

Da Volterra SAS

Enterome Bioscience SA, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 52500
Site License
USD 1500 INR 105000
Corporate User License
USD 2250 INR 157500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com